FDAnews Drug Daily Bulletin

Ohio Among States in Settlement with Pharmaceutical Giant

Aug. 8, 2014

Ohio Attorney General Mike DeWine announced the agreement and said the settlement will resolve allegations that Wyeth Pharmaceuticals unlawfully promoted Rapamune, a drug approved for use by kidney transplant patients. Pfizer, the parent company of Wyeth, agrees to be bound by the settlement.
Dayton Business Journal